Conclusions:
Our prospective, population-based observational study, performed in a first-level referring Hospital in a highly populated area, suggests some considerations. In a way, our data reported a significantly higher prevalence of HBV infection "contact" among our RA population, in comparison to the general one (p<0.05). This issue has previously been reported and could be justified but the generally higher HBV diffusion in certain area (i.e., Italy); by the age/ethnicity of the sample; and, finally, by the bias consisting in an extensive screening of these patients. On the other hand, our experience suggests that a tight monitoring of parameters predicting infectious flare should lead to a prompt diagnosis and a lower number of complications for these peculiar patients, as observed in our population. The relationship between disease activity and lipid metabolism is a notable in research surrounding rheumatoid arthritis (RA). RA patients without disease control reportedly show high titers of leptin or adiponectin as adipocytokines 2 . Objectives: We analyzed the interaction between changes in disease activity and adipocytokines using data from the TOMORROW (TOtal Management Of Risk factors in Rheumatoid arthritis patients to lOWer morbidity and mortality clinical trial) study, a 10-year prospective study (registration number, UMIN000003876). Methods: We analyzed data collected from the cohort of the TOMORROW study including 193 patients with RA and age-and sex-matched 194 healthy individuals (controls). We compared changes in leptin and adiponectin ( leptin and adiponectin) in both groups between baseline and after 3 years. Correlations with the change in disease activity ( DAS28ESR) during 3 years and changes in leptin and adiponectin in RA were investigated by univariate analysis. Results: Leptin levels increased in both groups. No significant differences in leptin were seen between RA (0.21 ng/ml) and controls (0.18 ng/ml; p=0.37). On the other hand, adiponectin was significantly decreased in controls (-3.3 μg/ml) compared to RA (-1.8 μg/ml; p=0.01). Negative correlations between leptin and adiponectin were detected in the RA group (r=-0.29, p<0.01). The correlation between adiponectin and DAS28ESR was positive both at baseline (r=0.22, p=0.01) and after 3 years (r=0.18, p=0.01). However, no such tendencies were seen for leptin. Table 1 shows details of the correlations with changes in adipocytokine. In terms of the relationship with DAS28ESR, no correlation was seen with leptin (r=0.07, p=0.31) or adiponectin (r=-0.01, p=0.91). Changes in lipid metabolic markers and fat percentages were detected as predictive factors for adipocytokines. Background: Data suggest infertility is increased in women with rheumatoid arthritis (RA) compared to healthy women. Therefore, it is possible that diminished ovarian reserve and ovulatory dysfunction may be more common among women with RA. Objectives: To compare differences in ovarian reserve and ovulatory frequency, as well as in self-reported infertility, between women with and without RA. Methods: Women with RA aged 20-40 seen in a university clinic without a history of ovarian surgery or prior exposure to possible ovary-toxic medications were invited to participate in a cross-sectional survey. Healthy controls were women aged 20-40 without an autoimmune disease, matched for age and current use of hormonal contraceptives. Infertility was defined as a patient reporting physician-diagnosed infertility or being unable to get pregnant after 12 months of trying. Ovarian reserve was assessed by measuring anti-Müllerian hormone (AMH). In women who were not taking hormonal contraceptives, progesterone level was measured from a serum sample drawn between days 21 and 23 of the menstrual cycle. Anovulation was defined as a progesterone level <3 ng/mL. In
